Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI), along with optimal medical therapy, improves clinical outcome by targeting ischemia-inducing stenosis. Yet, plaque progression or stent failure may cause recurring cardiac events. We assessed the potential prognostic role of different inflammatory biomarkers, known to be associated with plaque progression or stent failure, in patients undergoing FFR-guided PCI.
Fracassi, F., Niccoli, G., Scalone, G., Di Gioia, G., Conte, M., Bartunek, J., Sgueglia, G. A., De Bruyne, B., Montone, R. A., Wijns, W., Crea, F., Barbato, E., Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty, <<JOURNAL OF CARDIOVASCULAR MEDICINE>>, 2015; (Novembre): 687-693. [doi:10.2459/JCM.0000000000000342] [http://hdl.handle.net/10807/69172]
Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty
Fracassi, Francesco;Niccoli, Giampaolo;Scalone, Giancarla;Sgueglia, Gregory Angelo;Montone, Rocco Antonio;Crea, Filippo;
2015
Abstract
Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI), along with optimal medical therapy, improves clinical outcome by targeting ischemia-inducing stenosis. Yet, plaque progression or stent failure may cause recurring cardiac events. We assessed the potential prognostic role of different inflammatory biomarkers, known to be associated with plaque progression or stent failure, in patients undergoing FFR-guided PCI.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
